Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Akero Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 103 | 1 | 97 | −5 |
| Shares | 28.0M | 2.03K | 35.3M | +7.33M (+26.2%) |
| Value | $626.0M | $45.0K | $746.8M | +$120.8M (+19.3%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Akero Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Skorpios Trust | 4,907,829 | $103.8M | 22.97% |
| Atlas Venture Life Science Advisors, LLC | 2,232,251 | $47.2M | 4.34% |
| Millennium Management LLC | 19,743 | $418.0K | 0.00% |
| HRT Financial LP | 12,881 | $272.0K | 0.00% |
| Woodmont Investment Counsel LLC | 9,620 | $203.0K | 0.03% |
| Marshall Wace, LLP | 4,082 | $86.0K | 0.00% |
| Cambridge Trust Co | 3,500 | $74.0K | 0.00% |
| SOA Wealth Advisors, LLC. | 203 | $4.00K | 0.00% |
| CWM, LLC | 102 | $2.00K | 0.00% |
| Fortitude Advisory Group L.L.C. | 71 | $2.00K | 0.00% |
| CoreCap Advisors, LLC | 50 | $1.00K | 0.00% |
Sold out (16)
Institutions that held Akero Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Kore Private Wealth LLC | 305,376 | $6.83M |
| SG Americas Securities, LLC | 52,255 | $1.17M |
| Belpointe Asset Management LLC | 21,890 | $489.0K |
| Stansberry Asset Management, LLC | 21,883 | $489.0K |
| Winton Group Ltd | 16,330 | $365.0K |
| Simplex Trading, LLC | 11,642 | $295.0K |
| Parametric Portfolio Associates LLC | 9,254 | $207.0K |
| Nan Fung Group Holdings Ltd | 3,470 | $78.0K |
| Penserra Capital Management LLC | 800 | $17.0K |
| Point72 Hong Kong Ltd | 650 | $15.0K |
| Evolution Wealth Advisors, LLC | 211 | $5.00K |
| Brewin Dolphin Ltd | 100 | $2.23K |
| Johnson Midwest Financial, LLC | 103 | $2.00K |
| Toth Financial Advisory Corp | 50 | $1.00K |
| Signaturefd, LLC | 48 | $1.00K |
| Geneos Wealth Management Inc. | 50 | $1.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Akero Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| First Mercantile Trust Co | 2,030 | $45.0K |